Wednesday, 12 December 2018

FDA declines to approve reformulated Mallinckrodt opioid

Mallinckrodt Plc said on Wednesday the U.S. Food and Drug Administration declined to approve an abuse-deterrent version of its opioid painkiller Roxicodone.


No comments:

Post a Comment